bpc-157 chemical structure The Truth Behind BPC-157 Research Overview: Mechanisms and

Inconsistent refrigeration

doi: 10.1136/ard.2010.143040 Summary Keywords rheumatoid arthritis, targets, proteins, small molecular metabolites, epigenetic regulators Citation Huang J, Fu X, Chen X, Li Z, Huang Y and Liang C (2021) Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis

The FDA classifies BPC-157 as a Category 2 bulk drug substance meaning its not FDA-approved for human use and has been flagged as potentially presenting safety risks in unregulated compounding

Due to its versatility, it has become a key compound in the realm of regenerative medicine

Secondary Mechanisms: FAK-Paxillin and Growth Hormone Receptor Beyond the two primary pathways, published studies have identified additional mechanisms relevant to specific tissue types

If you have a different vial strength, use the calculator above or the Common Examples table below